BiomedicalPublications

Drug Research

Thieme Medical Publishers (Germany)·Germany·ISSN 2194-9379

Subscription or hybridMedicine

Drug Research is published by Thieme Medical Publishers (Germany) as a subscription journal (ISSN 2194-9379). No open-access article processing charge is listed; publishing is typically via subscription. Its OpenAlex h-index is 49. Figures on this page are sourced from OpenAlex and DOAJ and should be confirmed on the journal’s own site before submission.

Cost to publish

Subscription

No open-access fee found. Publishing is typically free to the author.

Checked · How we source APCs

Time to publication

—

Not reported to DOAJ.

h-index

49

OpenAlex citation statistic. Not a Journal Impact Factor.

2-year mean citedness

3.1

Average citations to articles from the previous two years.

What it costs to publish here

We could not find a published fee for Drug Research. As a subscription or hybrid journal, publishing is normally free unless you choose the open-access option.

Peer review and licensing

Review modelNot reported
LicenceNot reported
Author keeps copyrightNot reported
Plagiarism screeningNot reported
Editorial boardNot linked in DOAJ
LanguagesNot reported

Verification checks

2 of 8 confirmed

These are facts we could verify in public records, not a verdict. A journal missing a check is not necessarily disreputable — many long-established subscription journals sit outside the open-access registries entirely. Use them as questions to ask, and confirm anything that matters directly with the journal before you submit.

  • Listed in the Directory of Open Access JournalsNot listed. Many legitimate subscription journals are not in DOAJ, so this alone means little.
  • Included in OpenAlex's curated core setOpenAlex flags well-established venues that appear across major indexes.
  • Peer review model publicly declaredNo declared model found in DOAJ.
  • Publication charges stated up frontA journal that will not tell you the fee before submission is worth a second look.
  • Screens submissions for plagiarismReported to DOAJ by the journal.
  • Participates in a digital preservation schemeArchiving means the record survives if the publisher does not.
  • Assigns persistent identifiers (DOIs)Standard practice; its absence is unusual.
  • Still actively publishingMost recent indexed article: 2026.

Scope

The subjects Drug Research publishes most, derived from the topics assigned to its indexed articles.

Synthesis and biological activityAnalytical Methods in PharmaceuticalsComputational Drug Discovery MethodsAntibiotics Pharmacokinetics and EfficacyDiabetes Treatment and ManagementPharmacogenetics and Drug MetabolismPharmaceutical studies and practicesDrug Solubulity and Delivery SystemsInflammatory mediators and NSAID effectsNanoparticle-Based Drug Delivery

Publication record

Indexed articles1,423
Total citations14,773
i10-index453
Most recent indexed article2026
All ISSNs2194-9379, 2194-9387

Counts reflect what OpenAlex has indexed and will differ from the publisher's own figures. We do not show a founding year: OpenAlex's first-publication dates are distorted by mis-dated records — it puts PLoS ONE in 1806 — and we would rather omit a number than print one we cannot stand behind.